Use of oxidized regenerated cellulose to prevent pocket hematomas after cardiac electronic device implantation in patients on anticoagulants or dual antiplatelet therapy.

[1]  J. Geller,et al.  Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat Hemostat versus standard of care. , 2012, International journal of cardiology.

[2]  D. Haines,et al.  Risk of Hematoma Complications After Device Implant in the Clopidogrel Era , 2010, Circulation. Arrhythmia and electrophysiology.

[3]  M. Gold.  Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial , 2010 .

[4]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[5]  D. Milic,et al.  Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  W. Stummer,et al.  The use of local agents: Surgicel and Surgifoam. , 2005 .

[7]  H. Schunkert,et al.  Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. , 2004, Chest.

[8]  S. Rothenburger,et al.  In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. , 2003, Surgical infections.

[9]  G. Degenshein,et al.  EXPERIENCE WITH REGENERATED OXIDIZED CELLULOSE. , 1963, New York state journal of medicine.